Альтернативи пошуку:
revolves. » evolves. (Розширити пошук), resolves. (Розширити пошук), evolved. (Розширити пошук)
revolves. » evolves. (Розширити пошук), resolves. (Розширити пошук), evolved. (Розширити пошук)
-
2621
Table_1_Discovery of All Three Types in Cartilaginous Fishes Enables Phylogenetic Resolution of the Origins and Evolution of Interferons.docx
Опубліковано 2019“...We show that IFN3 groups sister to IFN1, resolve the origins of the human IFN3 lineages, and find that intronless IFN3s emerged at least three times. ...”
-
2622
Data_Sheet_1_Discovery of All Three Types in Cartilaginous Fishes Enables Phylogenetic Resolution of the Origins and Evolution of Interferons.docx
Опубліковано 2019“...We show that IFN3 groups sister to IFN1, resolve the origins of the human IFN3 lineages, and find that intronless IFN3s emerged at least three times. ...”
-
2623
Clamshell Approach for Growing Teratoma Syndrome
Опубліковано 2021“...The left superior pulmonary vein was encircled to ensure its control in case of lung involvement. The underlying left lung was freed of the compressing mass, which was a 2500 g tumor measuring 23 x 16 x 15 cm. ...”
-
2624
Acute vulvar and upper thigh ulceration associated with primary EBV in an elderly female.
Опубліковано 2020“...In addition, these ulcerations also took longer to resolve than Lipschütz ulcers of previous reports....”
-
2625
Table_1_Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial...
Опубліковано 2022“...Eligible participants attended nine 30-min ISF-NF training sessions involving three cortical regions linked to pain. Feasibility measures were monitored during the trial period. ...”
-
2626
DataSheet_2_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.csv
Опубліковано 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2627
Timing of Antibiotic Prophylaxis in Elective Caesarean Delivery: A Multi-Center Randomized Controlled Trial and Meta-Analysis
Опубліковано 2015“...</p><p>Methods</p><p>We conducted a randomized open-label controlled trial with two parallel arms at three hospitals in western China. Participants meeting the inclusion criteria received antibiotics 30-60 minutes before skin incision while others received antibiotics after umbilical cords clamping. ...”
-
2628
Table1_Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis.docx
Опубліковано 2023“...</p><p>Results: There were five studies involving 492 patients included in the study. Combination therapy did not significantly improve clinical outcomes in terms of 1-year OS [RR = 1.02, 95%CI = (0.82–1.25)], 2-year OS [RR = 1.00, 95%CI = (0.67–1.49)], 4-month PFS [RR = 1.00, 95%CI = (0.67–1.49)], 1-year PFS [RR = 0.79, 95%CI = (0.44–1.42)], and ORR [OR = 0.79, 95%CI = (0.49–1.27)] compared to chemotherapy alone, and the subgroup analysis of 2-year OS, 1-year PFS, and ORR based on countries and tumor sites showed similar results. ...”
-
2629
Early Sitting in Ischemic Stroke Patients (SEVEL): A Randomized Controlled Trial
Опубліковано 2016“...Taking these limitations into account, our results may help guide the development of more effective acute stroke rehabilitation strategies, and the design of future acute stroke trials involving out of bed activities and other mobilization regimens....”
-
2630
DataSheet_1_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.csv
Опубліковано 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2631
DataSheet_1_Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.docx
Опубліковано 2023“...Introduction<p>Drug resistance is a major obstacle in cancer treatment and can involve a variety of different factors. Identifying effective therapies for drug resistant tumors is integral for improving patient outcomes....”
-
2632
Robotic-Assisted Middle Lobe Sleeve Lobectomy for Carcinoid Tumor
Опубліковано 2023“...</p> <p>Preoperative bronchoscopy confirmed the involvement of the insertion of middle lobe bronchus. ...”
-
2633
Modulated Preparation and Structural Diversification of Zn<sup>II</sup> and Cd<sup>II</sup> Metal−Organic Frameworks with a Versatile Building Block 5-(4-Pyridyl)-1,3,4-oxadiazole-...
Опубліковано 2006“...Four types of binding modes involving monodentate (η-<i>N</i><sub>oxa</sub>), bidentate (μ-<i>N</i><sub>py</sub>,<i>N</i><sub>oxa</sub>, or μ-<i>N</i><sub>py</sub>,<i>S</i>,<i>S</i>) and tridentate (μ-<i>N</i><sub>py</sub>,<i>N</i><sub>oxa</sub>,<i>S</i>) are observed. ...”
-
2634
Data_Sheet_1_The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials.docx
Опубліковано 2022“...In total, 22 eligible RCTs (44 study arms; 1,348 patients) involving nine endovascular modalities or combinations [balloon angioplasty (BA), drug-coated balloon (DCB), drug-eluting stent (DES), atherectomy device + BA (AD + BA), AD + DCB, balloon-expandable bare metal stent (BMS), self-expanding stent (SES), absorbable metal stents (AMS), and inorganics-coated stent (ICS)] were included. ...”
-
2635
Image_1_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2636
Table_2_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2637
Table_1_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2638
Image_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2639
Table_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”
-
2640
Image_3_The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis...
Опубліковано 2020“...</p>Results<p>27 publications (comprising 9 active intervention arms), involving 8,388 TC patients, were selected. ...”